After Novartis left, Boehringer bets up to $500M on the field of prescription smartphone app

After Novartis left, Boehringer bets up to $500M on the field of prescription smartphone app

Source: 
Endpoints
snippet: 

Boehringer Ingelheim wants in on digital therapeutics.

The German pharma signed an up to $500 million collaboration with Click Therapeutics, one of a handful of major companies developing prescription computer and smartphone applications for various neurological or mental disorders. They join a small list of pharmas that have decided to test the waters in the emerging field.